235 related articles for article (PubMed ID: 19010836)
1. Role of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemia.
Inthal A; Krapf G; Beck D; Joas R; Kauer MO; Orel L; Fuka G; Mann G; Panzer-Grümayer ER
Clin Cancer Res; 2008 Nov; 14(22):7196-204. PubMed ID: 19010836
[TBL] [Abstract][Full Text] [Related]
2. ETV6-RUNX1 promotes survival of early B lineage progenitor cells via a dysregulated erythropoietin receptor.
Torrano V; Procter J; Cardus P; Greaves M; Ford AM
Blood; 2011 Nov; 118(18):4910-8. PubMed ID: 21900195
[TBL] [Abstract][Full Text] [Related]
3. Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice.
van der Weyden L; Giotopoulos G; Rust AG; Matheson LS; van Delft FW; Kong J; Corcoran AE; Greaves MF; Mullighan CG; Huntly BJ; Adams DJ
Blood; 2011 Jul; 118(4):1041-51. PubMed ID: 21628403
[TBL] [Abstract][Full Text] [Related]
4. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M
Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299
[TBL] [Abstract][Full Text] [Related]
5. ETV6/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cells.
Kantner HP; Warsch W; Delogu A; Bauer E; Esterbauer H; Casanova E; Sexl V; Stoiber D
Neoplasia; 2013 Nov; 15(11):1292-300. PubMed ID: 24339741
[TBL] [Abstract][Full Text] [Related]
6. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
[TBL] [Abstract][Full Text] [Related]
7. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
[TBL] [Abstract][Full Text] [Related]
8.
Montaño A; Ordoñez JL; Alonso-Pérez V; Hernández-Sánchez J; Santos S; González T; Benito R; García-Tuñón I; Hernández-Rivas JM
Cells; 2020 Jan; 9(1):. PubMed ID: 31952221
[TBL] [Abstract][Full Text] [Related]
9. A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia.
Yang YL; Yen CT; Pai CH; Chen HY; Yu SL; Lin CY; Hu CY; Jou ST; Lin DT; Lin SR; Lin SW
PLoS One; 2015; 10(11):e0142863. PubMed ID: 26580398
[TBL] [Abstract][Full Text] [Related]
10. EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
Reinbothe S; Larsson AM; Vaapil M; Wigerup C; Sun J; Jögi A; Neumann D; Rönnstrand L; Påhlman S
Biochem Biophys Res Commun; 2014 Feb; 445(1):163-9. PubMed ID: 24502950
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin drives breast cancer progression by activation of its receptor EPOR.
Chan KK; Matchett KB; Coulter JA; Yuen HF; McCrudden CM; Zhang SD; Irwin GW; Davidson MA; Rülicke T; Schober S; Hengst L; Jaekel H; Platt-Higgins A; Rudland PS; Mills KI; Maxwell P; El-Tanani M; Lappin TR
Oncotarget; 2017 Jun; 8(24):38251-38263. PubMed ID: 28418910
[TBL] [Abstract][Full Text] [Related]
12. RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia.
Sharma G; Tran TM; Bansal I; Beg MS; Bhardwaj R; Bassi J; Tan Y; Jaiswal AK; Tso C; Jain A; Singh J; Chattopadhyay P; Singh A; Chopra A; Bakhshi S; Casero D; Rao DS; Palanichamy JK
J Exp Clin Cancer Res; 2023 Sep; 42(1):231. PubMed ID: 37670323
[TBL] [Abstract][Full Text] [Related]
13. ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia.
Stoskus M; Vaitkeviciene G; Eidukaite A; Griskevicius L
Blood Cells Mol Dis; 2016 Mar; 57():30-4. PubMed ID: 26852652
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of monitoring ETV6-RUNX1 fusion gene expression in children with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
Hong Y; Qin YZ; Xu YY; Zhou SH; Wang Y; Xu LP; Zhang XH; Huang XJ; Zhao XS
Zhonghua Xue Ye Xue Za Zhi; 2017 Aug; 38(8):680-684. PubMed ID: 28954346
[No Abstract] [Full Text] [Related]
15. Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.
Burmeister T; Gökbuget N; Schwartz S; Fischer L; Hubert D; Sindram A; Hoelzer D; Thiel E
Haematologica; 2010 Feb; 95(2):241-6. PubMed ID: 19713226
[TBL] [Abstract][Full Text] [Related]
16. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer.
Hu W; Zhang Y; Jiang Z; Wang L; Li J; Chen S; Dai N; Si J
Tumour Biol; 2016 Aug; 37(8):11523-33. PubMed ID: 27086036
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of ETV6-RUNX1 fusion gene in children with acute lymphoblastic leukemia in China.
Gao YJ; Zhu XH; Yang Y; Wu Y; Lu FJ; Zhai XW; Wang HS
Cancer Genet Cytogenet; 2007 Oct; 178(1):57-60. PubMed ID: 17889709
[TBL] [Abstract][Full Text] [Related]
18. Outcome and Prognostic Factors for
Lee JW; Kim SK; Jang PS; Chung NG; Jeong DC; Kim M; Cho B; Kim HK
Cancer Res Treat; 2017 Apr; 49(2):446-453. PubMed ID: 27506214
[TBL] [Abstract][Full Text] [Related]
19. Blocking ETV6/RUNX1-induced MDM2 overexpression by Nutlin-3 reactivates p53 signaling in childhood leukemia.
Kaindl U; Morak M; Portsmouth C; Mecklenbräuker A; Kauer M; Zeginigg M; Attarbaschi A; Haas OA; Panzer-Grümayer R
Leukemia; 2014 Mar; 28(3):600-8. PubMed ID: 24240203
[TBL] [Abstract][Full Text] [Related]
20. Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocol.
Gandemer V; Chevret S; Petit A; Vermylen C; Leblanc T; Michel G; Schmitt C; Lejars O; Schneider P; Demeocq F; Bader-Meunier B; Bernaudin F; Perel Y; Auclerc MF; Cayuela JM; Leverger G; Baruchel A;
Haematologica; 2012 Nov; 97(11):1743-50. PubMed ID: 22580999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
